Researchers identify key regulators involved in genesis of multiple sclerosis lesions

By means of CRISPR screening, LMU researchers have provided the first ever comprehensive molecular characterization of T cell infiltration into the central nervous system of people with MS.

HF-158K1 by HighField Biopharmaceuticals for Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer): Likelihood of Approval

HF-158K1 is under clinical development by HighField Biopharmaceuticals and currently in Phase I for Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast

July 6, 2024

Study: A planet-friendly diet could help people to live longer and healthier

Eating more planet-friendly foods could help you live a longer, healthier life, according to new research. Researchers found that people who followed a more environmentally

July 24, 2023

D-Mannose Fails to Prevent Recurrent UTIs

D-mannose did not reduce the proportion of women with recurrent urinary tract infection (UTI), the randomized, placebo-controlled MERIT trial showed. Over the 6-month study period,

April 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.